Kolexia
Cohen Anita
Pharmacien
Hôpital La Timone Enfants
Marseille, France
36 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leishmaniose Paludisme Maladie du sommeil Parasitémie Paludisme à Plasmodium falciparum Méningiome Leishmaniose viscérale Tumeurs des méninges Récidive tumorale locale

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Role of the European Pharmacist in the Implementation of the Latest WHO Guidelines for Malaria.
Pathogens (Basel, Switzerland)   17 mai 2023
Design, Synthesis, and Antiprotozoal Evaluation of New Promising 2,9- (substituted-aminomethyl)-4,7-phenyl-1,10-phenanthroline Derivatives, a Potential Alternative Scaffold to Drug Efflux.
Pathogens (Basel, Switzerland)   13 novembre 2022
Challenges and Tools for In Vitro Exploratory Screening in the Drug Development Process: An Updated Review.
Pathogens (Basel, Switzerland)   10 décembre 2021
Design, synthesis, and characterization of novel aminoalcohol quinolines with strong in vitro antimalarial activity.
European journal of medicinal chemistry   10 novembre 2021
A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Microbiology spectrum   29 septembre 2021
2-Phenoxy-3-Trichloromethylquinoxalines Are Antiplasmodial Derivatives with Activity against the Apicoplast of .
Pharmaceuticals (Basel, Switzerland)   26 juillet 2021
Design, synthesis, and antiprotozoal evaluation of new 2,4-bis(substituted-aminomethyl)phenylquinoline, 1,3-bis(substituted-aminomethyl)phenylisoquinoline and 2,4-bis(substituted-aminomethyl)phenylquinazoline derivatives.
Journal of enzyme inhibition and medicinal chemistry   05 mars 2020
Synthesis and in vitro evaluation of new 5-substituted 6-nitroimidazooxazoles as antikinetoplastid agents.
European journal of medicinal chemistry   14 février 2020
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research   22 janvier 2020
Nongenotoxic 3-Nitroimidazo1,2- pyridines Are NTR1 Substrates That Display Potent Antileishmanial Activity.
ACS medicinal chemistry letters   19 décembre 2018